Sohail Kareem, MD in Tulsa, OK - Medicare Nephrology

Sohail Kareem, MD is a medicare enrolled "Internal Medicine - Nephrology" physician in Tulsa, Oklahoma. He graduated from medical school in 1999 and has 25 years of diverse experience with area of expertise as Nephrology. He is a member of the group practice Osteopathic Physicians Of Tulsa, Inc. and his current practice location is 6465 S Yale Ave Ste 401, Tulsa, Oklahoma. You can reach out to his office (for appointments etc.) via phone at (918) 582-3154.

Sohail Kareem is licensed to practice in Oklahoma (license number 28681) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1396760112.

Contact Information

	Sohail Kareem, MD
	6465 S Yale Ave Ste 401, Tulsa, OK 74136-7806
	(918) 582-3154
	(918) 582-3593

Physician's Profile

Full Name	Sohail Kareem
Gender	Male
Speciality	Nephrology
Experience	25 Years
Location	6465 S Yale Ave Ste 401, Tulsa, Oklahoma
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Sohail Kareem graduated from medical school in 1999

NPI Data:

NPI Number: 1396760112
Provider Enumeration Date: 07/13/2006
Last Update Date: 07/18/2023

Medicare PECOS Information:

PECOS PAC ID: 6103820873
Enrollment ID: I20120130000251

Medical Identifiers

Medical identifiers for Sohail Kareem such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1396760112	NPI	-	NPPES
200395800A	Medicaid	OK

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RN0300X	Internal Medicine - Nephrology	28681 (Oklahoma)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Fmcna - South Tulsa	Tulsa, OK	Dialysis facility
Davita - Wagoner Dialysis	Wagoner, OK	Dialysis facility
Fmcna - Muskogee	Muskogee, OK	Dialysis facility
Davita - Southcrest	Tulsa, OK	Dialysis facility
Saint Francis Hospital, Inc	Tulsa, OK	Hospital
Oklahoma State University Medical Center	Tulsa, OK	Hospital
Hillcrest Hospital South	Tulsa, OK	Hospital
St John Medical Center, Inc	Tulsa, OK	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Osteopathic Physicians Of Tulsa, Inc.	1850383662	9

News Archive

Researchers devise new technique to deliver cancer treatment

A team of researchers has devised a new way to target tumors with cancer-fighting drugs, a discovery that may lead to clinical treatments for cancer patients.

Ventana, leading cancer researchers partner to commercialize novel IHC primary antibody

Ventana Medical Systems, Inc., a member of the Roche Group, has signed an exclusive license agreement with the German Cancer Research Center and University Hospital Heidelberg, Germany to commercialize a novel immunohistochemistry (IHC) primary antibody developed by researchers Andreas von Deimling, MD, Hanswalter Zentgraf, PhD and David Capper, MD, to detect the V600E BRAF mutation protein.

Rare inherited enzyme disorder offers new clues about fibrotic conditions

What can a family of rare inherited disorders teach scientists about more common health problems like fibrosis? Plenty, based on research led by St. Jude Children's Research Hospital scientists that appears today in the journal Science Advances.

GlobalData: Nearly 70–100% of aesthetic procedures in the U.S. estimated to be delayed due to COVID-19

Between 70–100% of all the aesthetic procedures performed in the US are estimated to be delayed, postponed or canceled due to COVID-19, as they are considered to be elective and non-essential, according to GlobalData, a leading data and analytics company.

Scotland says no to prostate cancer drug Abiraterone

Patients with advanced prostate cancer in Scotland will not get access to a new drug which can extend their lives by more than three months. Prostate cancer is the most common cancer to affect men and the second most common cause of death.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Sohail Kareem allows following entities to bill medicare on his behalf.

Entity Name	Osteopathic Physicians Of Tulsa, Inc.
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1487735593 PECOS PAC ID: 1850383662 Enrollment ID: O20040401000449

News Archive

Researchers devise new technique to deliver cancer treatment

A team of researchers has devised a new way to target tumors with cancer-fighting drugs, a discovery that may lead to clinical treatments for cancer patients.

Ventana, leading cancer researchers partner to commercialize novel IHC primary antibody

Rare inherited enzyme disorder offers new clues about fibrotic conditions

GlobalData: Nearly 70–100% of aesthetic procedures in the U.S. estimated to be delayed due to COVID-19

Scotland says no to prostate cancer drug Abiraterone

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sohail Kareem is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Sohail Kareem, MD 6465 S Yale Ave Ste 401, Tulsa, OK 74136-7806 Ph: (918) 582-3154	Sohail Kareem, MD 6465 S Yale Ave Ste 401, Tulsa, OK 74136-7806 Ph: (918) 582-3154

News Archive

Researchers devise new technique to deliver cancer treatment

A team of researchers has devised a new way to target tumors with cancer-fighting drugs, a discovery that may lead to clinical treatments for cancer patients.

Ventana, leading cancer researchers partner to commercialize novel IHC primary antibody

Rare inherited enzyme disorder offers new clues about fibrotic conditions

GlobalData: Nearly 70–100% of aesthetic procedures in the U.S. estimated to be delayed due to COVID-19

Scotland says no to prostate cancer drug Abiraterone

Internal Medicine Doctors in Tulsa, OK

Sarah Anne Shaw-dressler, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 6151 S Yale Ave Ste 100a, Tulsa, OK 74136 Phone: 918-494-8500 Fax: 918-307-5578
Julia Margaret Kwon, DO Nephrology Medicare: Medicare Enrolled Practice Location: 1705 E 19th St Ste 302, Tulsa, OK 74104 Phone: 918-748-7585 Fax: 918-748-7539
Peter Madden, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4502 E 41st St, Tulsa, OK 74135 Phone: 918-619-4400
Thao Tran, D.O Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4502 E. 41st Street, Tulsa, OK 74135 Phone: 918-619-4400
Robert Peter Aran, D.O. Nephrology Medicare: Medicare Enrolled Practice Location: 6160 S Yale Ave Ste 100, Tulsa, OK 74136 Phone: 918-497-3300 Fax: 918-497-3365
Robert Dean Okada, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 6151 S Yale Ave, Ste 304, Tulsa, OK 74136 Phone: 918-494-5300 Fax: 918-494-5455
Dr. Charles Wade Taylor, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 12697 E 51st St, Tulsa, OK 74146 Phone: 918-505-3200 Fax: 918-505-3253

Sohail Kareem, MD - Medicare Nephrology in Tulsa, OK

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Researchers devise new technique to deliver cancer treatment

Ventana, leading cancer researchers partner to commercialize novel IHC primary antibody

Rare inherited enzyme disorder offers new clues about fibrotic conditions

GlobalData: Nearly 70–100% of aesthetic procedures in the U.S. estimated to be delayed due to COVID-19

Scotland says no to prostate cancer drug Abiraterone

Medicare Reassignments

Researchers devise new technique to deliver cancer treatment

Ventana, leading cancer researchers partner to commercialize novel IHC primary antibody

Rare inherited enzyme disorder offers new clues about fibrotic conditions

GlobalData: Nearly 70–100% of aesthetic procedures in the U.S. estimated to be delayed due to COVID-19

Scotland says no to prostate cancer drug Abiraterone

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Researchers devise new technique to deliver cancer treatment

Ventana, leading cancer researchers partner to commercialize novel IHC primary antibody

Rare inherited enzyme disorder offers new clues about fibrotic conditions

GlobalData: Nearly 70–100% of aesthetic procedures in the U.S. estimated to be delayed due to COVID-19

Scotland says no to prostate cancer drug Abiraterone

Internal Medicine Doctors in Tulsa, OK